Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope...

    2026-01-18

    Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Protein Purification

    Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-residue tag derived from the human influenza virus hemagglutinin protein, widely used for protein detection and purification [APExBIO product]. Its high solubility values — ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water — enable broad compatibility with experimental buffers. The HA peptide functions as a competitive ligand for anti-HA antibodies, facilitating the elution of HA-tagged proteins in immunoprecipitation assays [Dong et al., 2025]. High purity (>98%) confirmed by HPLC and mass spectrometry ensures reliability in advanced protein interaction and ubiquitination studies. Proper storage (desiccated at -20°C) maintains stability, but long-term solution storage is not advised [APExBIO].

    Biological Rationale

    The HA tag is a linear epitope derived from the influenza hemagglutinin protein, originally mapped for selective antibody recognition. The nine-amino acid sequence (YPYDVPDYA) is not commonly found in mammalian proteomes, reducing cross-reactivity in immunodetection. This tag enables detection, affinity purification, and elution of HA-tagged fusion proteins. It is widely used in protein-protein interaction studies, especially in the context of understanding post-translational modifications like ubiquitination, as seen in studies involving PRMT5 and NEDD4L [Dong et al., 2025]. The HA tag’s compact size limits its effect on protein folding and function, making it suitable for translational and mechanistic research [LabPE]. This article extends previous summaries by providing updated benchmarks and mechanistic context for HA peptide use in advanced ubiquitination and signaling pathway research.

    Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

    The Influenza Hemagglutinin (HA) Peptide acts as a competitive inhibitor for anti-HA antibodies. When introduced into immunoprecipitation or affinity purification workflows, the free HA peptide binds to antibody paratopes, displacing HA-tagged fusion proteins bound to the solid-phase antibody or bead. This enables controlled elution and recovery of tagged proteins without harsh denaturing conditions. The peptide’s high purity and sequence fidelity, as verified by HPLC and mass spectrometry, minimize off-target effects. Its high solubility in multiple solvents (DMSO, ethanol, water) facilitates compatibility with diverse buffers and elution protocols [APExBIO]. The HA tag’s sequence has been validated for selective recognition by monoclonal anti-HA antibodies (e.g., clone 12CA5), supporting sensitive detection and quantification in immunoblotting, ELISA, and immunofluorescence assays [EpitopePeptide]. This competitive binding mechanism is critical for advanced protein-protein interaction mapping and has been utilized in studies analyzing PRMT5 ubiquitination and downstream signaling [Dong et al., 2025].

    Evidence & Benchmarks

    • High-purity HA peptide (>98%) confirmed by HPLC and MS ensures minimal nonspecific elution and robust assay reproducibility (APExBIO).
    • Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water at room temperature; enables flexible elution buffer design (APExBIO).
    • Tag sequence (YPYDVPDYA) is recognized by anti-HA monoclonal antibodies (clone 12CA5 and related), facilitating sensitive detection and purification across platforms (EpitopePeptide).
    • In translational research, HA tag-based immunoprecipitation enabled mapping of PRMT5 interactions and post-translational modifications in cell signaling studies (Dong et al., 2025).
    • Use of competitive HA peptide allows for non-denaturing elution, preserving protein complexes and activity for downstream assays (LabPE).

    Applications, Limits & Misconceptions

    The Influenza Hemagglutinin (HA) Peptide is used in:

    • Immunoprecipitation of HA-tagged fusion proteins for protein-protein interaction studies [R110-Azide-5-Isomer].
    • Competitive elution of tagged proteins from anti-HA magnetic beads or resin.
    • Detection of HA-tagged constructs by western blot, ELISA, and immunofluorescence.
    • Mapping ubiquitination and other post-translational modifications in complex signaling pathways [Dong et al., 2025].
    • High-throughput screening for interactome and protein complex characterization.

    This article clarifies and updates previous content such as "Unleashing Precision in Translational Research" by providing peer-reviewed, quantitative performance benchmarks and addressing misconceptions regarding tag effects on protein function.

    Common Pitfalls or Misconceptions

    • The HA peptide is not suitable for eluting proteins tagged with unrelated epitopes (e.g., FLAG, Myc, His tags).
    • Long-term storage of peptide solutions at room temperature or above -20°C leads to degradation and loss of activity.
    • Low pH or high-salt buffers can reduce antibody affinity and decrease elution efficiency.
    • Incorrect peptide sequence or low purity formulations can produce false negatives during immunodetection.
    • The HA tag may interfere with protein function if fused to essential domains or improperly positioned.

    Workflow Integration & Parameters

    For optimal results, the peptide should be reconstituted in water, DMSO, or ethanol at concentrations matching experimental requirements. Concentrations typically range from 1 to 5 mg/mL for competitive elution. For immunoprecipitation, add the peptide directly to the antibody-protein complex and incubate at 4°C for 30–60 minutes. Rapid elution is typically achieved within 5–15 minutes under gentle agitation. Peptide stocks should be stored desiccated at -20°C. Avoid repeated freeze-thaw cycles. The A6004 kit from APExBIO provides validated, high-purity HA peptide, ensuring batch-to-batch consistency [APExBIO]. For advanced guidance on integrating the HA tag in ubiquitination or signaling studies, see the broader mechanistic discussion in GTP-Binding Protein Fragment—this article updates those protocols with new quantitative solubility and purity benchmarks.

    Conclusion & Outlook

    The Influenza Hemagglutinin (HA) Peptide remains a gold standard for protein purification and detection in molecular biology. Its validated competitive binding mechanism, robust solubility, and high purity support reproducible workflows from discovery research to translational applications. As demonstrated in recent ubiquitination and cancer signaling studies [Dong et al., 2025], the HA tag continues to enable high-precision mapping of protein interactions and post-translational events. For up-to-date product specifications and ordering information, consult the official APExBIO Influenza Hemagglutinin (HA) Peptide product page.